A. Nolan

2.6k total citations
44 papers, 1.9k citations indexed

About

A. Nolan is a scholar working on Small Animals, Pharmacology and Genetics. According to data from OpenAlex, A. Nolan has authored 44 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Small Animals, 16 papers in Pharmacology and 8 papers in Genetics. Recurrent topics in A. Nolan's work include Veterinary Pharmacology and Anesthesia (16 papers), Inflammatory mediators and NSAID effects (8 papers) and Antibiotics Pharmacokinetics and Efficacy (7 papers). A. Nolan is often cited by papers focused on Veterinary Pharmacology and Anesthesia (16 papers), Inflammatory mediators and NSAID effects (8 papers) and Antibiotics Pharmacokinetics and Efficacy (7 papers). A. Nolan collaborates with scholars based in United Kingdom, Ireland and Japan. A. Nolan's co-authors include E. M. Scott, Jacqueline Reid, John L. Fitzpatrick, Jessica Reid, Elizabeth M. Welsh, Patricia Pawson, F.J. Young, Caroline J. Hogarth, P.D. Eckersall and Quintin McKellar and has published in prestigious journals such as Endocrinology, Annals of Oncology and Journal of Dairy Science.

In The Last Decade

A. Nolan

43 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Nolan United Kingdom 20 1.3k 403 353 326 253 44 1.9k
Andrea M. Nolan United Kingdom 25 1.3k 1.0× 139 0.3× 527 1.5× 426 1.3× 403 1.6× 43 2.0k
Jeff C. Ko United States 25 1.2k 0.9× 738 1.8× 597 1.7× 237 0.7× 510 2.0× 89 2.2k
A.E. Waterman United Kingdom 29 1.9k 1.5× 186 0.5× 224 0.6× 608 1.9× 744 2.9× 100 2.6k
B.C. McKusick United States 15 532 0.4× 324 0.8× 279 0.8× 76 0.2× 276 1.1× 19 1.1k
A. E. Waterman‐Pearson United Kingdom 24 1.9k 1.5× 80 0.2× 343 1.0× 785 2.4× 566 2.2× 39 2.4k
Didier Serteyn Belgium 28 360 0.3× 306 0.8× 161 0.5× 955 2.9× 314 1.2× 180 2.4k
Marja Raekallio Finland 30 2.4k 1.9× 183 0.5× 296 0.8× 1.0k 3.1× 744 2.9× 166 3.3k
A. Μ. Merritt United States 24 816 0.7× 612 1.5× 64 0.2× 1.2k 3.8× 368 1.5× 100 2.0k
Thomas J. Doherty United States 23 1.4k 1.1× 80 0.2× 52 0.1× 674 2.1× 767 3.0× 101 1.9k
Janeen L. Salak‐Johnson United States 25 923 0.7× 466 1.2× 346 1.0× 23 0.1× 168 0.7× 53 2.7k

Countries citing papers authored by A. Nolan

Since Specialization
Citations

This map shows the geographic impact of A. Nolan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Nolan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Nolan more than expected).

Fields of papers citing papers by A. Nolan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Nolan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Nolan. The network helps show where A. Nolan may publish in the future.

Co-authorship network of co-authors of A. Nolan

This figure shows the co-authorship network connecting the top 25 collaborators of A. Nolan. A scholar is included among the top collaborators of A. Nolan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Nolan. A. Nolan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nolan, A., et al.. (2025). The small molecule inhibitor 3PO is a modulator of neutrophil metabolism, ROS production, and NET release. Clinical & Experimental Immunology. 219(1). 3 indexed citations
3.
Nolan, A., et al.. (2023). Fluorescent characterization of differentiated myotubes using flow cytometry. Cytometry Part A. 105(5). 332–344. 4 indexed citations
4.
Nolan, A., R. Brett, Juliette A. Strauss, Claire E. Stewart, & Sam O. Shepherd. (2020). Short-term, but not acute, intake of New Zealand blackcurrant extract improves insulin sensitivity and free-living postprandial glucose excursions in individuals with overweight or obesity. European Journal of Nutrition. 60(3). 1253–1262. 18 indexed citations
5.
Reid, Jacqueline, A. Nolan, & E. M. Scott. (2018). Measuring pain in dogs and cats using structured behavioural observation. The Veterinary Journal. 236. 72–79. 72 indexed citations
6.
Reilly, David, et al.. (2018). BRCA1/BRCA2 predictive genetic testing in an Irish population: A missed opportunity. Annals of Oncology. 29. viii78–viii78. 1 indexed citations
7.
German, Alexander J., Shelley L. Holden, Lesley Wiseman‐Orr, et al.. (2011). Quality of life is reduced in obese dogs but improves after successful weight loss. The Veterinary Journal. 192(3). 428–434. 121 indexed citations
8.
Nolan, A. & Massimo Palmarini. (2007). Requirements for veterinary research and the recruitment of veterinary surgeons into research. Veterinary Record. 161(11). 368–370. 2 indexed citations
9.
Cheng, Zhangrui, A. Nolan, Ana Monteiro, & Q. McKellar. (2003). Enantioselective pharmacokinetics and cyclo‐oxygenase inhibition of carprofen and carprofen enantiomers in sheep. Journal of Veterinary Pharmacology and Therapeutics. 26(5). 391–394. 12 indexed citations
10.
Welsh, Elizabeth M., A. Nolan, & Jessica Reid. (1997). Beneficial effects of administering carprofen before surgery in dogs. Veterinary Record. 141(10). 251–253. 43 indexed citations
12.
McKellar, Quintin, et al.. (1997). Method for the growth of equine airway epithelial cells in culture. Research in Veterinary Science. 62(1). 30–33. 11 indexed citations
13.
Cheng, Zhangrui, Quintin McKellar, A. Nolan, & P. Lees. (1996). Preliminary pharmacokinetic and pharmacodynamic studies on flunixin meglumine in donkeys. Veterinary Research Communications. 20(5). 469–472. 7 indexed citations
14.
Correia, Dalmo, A. Nolan, & Jessica Reid. (1996). Pharmacokinetics of propofol infusions, either alone or with ketamine, in sheep premedicated with acepromazine and papaveretum. Research in Veterinary Science. 60(3). 213–217. 18 indexed citations
15.
Welsh, Elizabeth M. & A. Nolan. (1995). Effect of flunixin meglumine on the thresholds to mechanical stimulation in healthy and lame sheep. Research in Veterinary Science. 58(1). 61–66. 56 indexed citations
16.
Nolan, A., et al.. (1994). The effects of butorphanol on locomotor activity in ponies: a preliminary study. Journal of Veterinary Pharmacology and Therapeutics. 17(4). 323–326. 29 indexed citations
17.
Welsh, Elizabeth M., Quintin McKellar, & A. Nolan. (1993). The pharmacokinetics of flunixin meglumine in the sheep. Journal of Veterinary Pharmacology and Therapeutics. 16(2). 181–188. 47 indexed citations
18.
Nolan, A., Joanne Reid, & Suzanne Grant. (1993). The effects of halothane and nitrous oxide on the pharmacokinetics of propofol in dogs. Journal of Veterinary Pharmacology and Therapeutics. 16(3). 335–342. 19 indexed citations
19.
Welsh, Elizabeth M., Peter Baxter, & A. Nolan. (1992). Pharmacokinetics of carprofen administered intravenously to sheep. Research in Veterinary Science. 53(2). 264–266. 27 indexed citations
20.
McKellar, Quintin, A. Nolan, & E.A. Galbraith. (1990). Serum thromboxane generation by platelets in several domestic animal species. British Veterinary Journal. 146(5). 398–404. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026